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Abstract
Human papillomaviruses (HPVs) of genus betapapillomavirus (betaHPV) are implicated in skin carcinogenesis, but their 
exact role in keratinocyte transformation is poorly understood. We show an interaction of HPV5 and HPV8 oncoproteins E6 
and E7 with the nuclear mitotic apparatus protein 1 (NuMA). Binding of E6 or E7 to NuMA induces little aneuploidy, cell 
cycle alterations, or aberrant centrosomes. Intracellular localization of NuMA is not altered by E6 and E7 expression in 2D 
cultures. However, the localization profile is predominantly cytoplasmic in 3D organotypic skin models. Both viral proteins 
colocalize with NuMA in interphase cells, while only E7 colocalizes with NuMA in mitotic cells. Intriguingly, a small 
subset of cells shows E7 at only one spindle pole, whereas NuMA is present at both poles. This dissimilar distribution of E7 
at the spindle poles may alter cell differentiation, which may in turn be relevant for betaHPV-induced skin carcinogenesis.
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Introduction
A role for human papillomaviruses (HPVs) of genus beta-
papillomavirus (betaHPV) in the development of nonmela-
noma skin cancer among immunosuppressed and immu-
nocompetent individuals has been proposed for decades. 
The oncogenic potential of betaHPV in skin carcinogenesis 
was originally identified in patients suffering from the rare 
inherited disease epidermodysplasia verruciformis (EV), 
who have an increased susceptibility to betaHPV infec-
tions. However, betaHPV can also be found in skin cancers 
of non-EV patients (reviewed in [1–3]). Recently, a prospec-
tive epidemiological study provided compelling evidence 
that betaHPV diversity and viral loads in the skin are asso-
ciated with squamous cell carcinogenesis [4]. Further sup-
port for an etiologic role arose from the observation that 
betaHPV is frequently detected in actinic keratoses, which 
are premalignant lesions of the skin [5]. Curiously, despite 
frequent detection of betaHPV DNA in premalignant lesions 
of immunocompetent patients, viral sequences are rarely 
found in skin tumors in these patients, pointing towards a 
hit-and-run mechanism by betaHPV in the carcinogenic 
process [6, 7].
To prove the oncogenic potential of betaHPV early pro-
teins in vivo, HPV8 transgenic mice were generated, in 
which the expression of the complete early genome region 
(CER) is under the control of the human keratin-14 promoter 
(K14-HPV8-CER). These animals develop papillomas, par-
tially along with moderate to severe dysplasia and squamous 
cell carcinoma (SCC) [8, 9].
Mechanistically, HPV5 and HPV8 E7 positive cells 
display hyperproliferation and are positive for both cyclin 
E and p16INK4a, indicating that E7 is able to overcome 
p16INK4a-induced cell cycle arrest [10]. BetaHPV E7 
oncoproteins bind pRb with lower affinity than high-risk 
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alphaHPV [11], and this binding is accompanied by degrada-
tion of pRb [12]. In particular, the E7 oncoprotein of HPV8 
proved to be the major mediator of keratinocyte invasion in 
3D organotypic skin cultures. E7 positive cells lose their 
polarity and migrate downwards into the extracellular matrix 
(ECM), concomitant with upregulation of matrix metallo-
proteases (MMP) [13]. In addition, E7-mediated invasion is 
directed by overexpression of integrin α3β1 and interaction 
of E7 positive cells with fibronectin in the ECM [14].
It has previously been shown that HPV6, HPV11, and 
HPV16 E7 proteins bind to nuclear mitotic apparatus pro-
tein 1 (NuMA) leading to the introduction of mitotic errors 
and aneuploidy [15]. NuMA is indispensable in organizing 
microtubules at centrosomes and in chromosome alignment 
during mitosis [16–18]. Furthermore, post-mitotic nuclear 
reassembly is dependent on NuMA, and NuMA is also a 
crucial structural component of the nuclear matrix dur-
ing interphase (reviewed in [19]). Another key function of 
NuMA is the control of cell polarity, which is important for 
asymmetric division of basal epithelial cells [20, 21].
In search for cellular interaction partners of HPV5 and 
HPV8 E6 and E7, we identified NuMA as a binding partner 
for these viral proteins and describe relevance of this asso-
ciation for keratinocyte homeostasis.
Materials and methods
Cell culture
293T and COS-7 cells were cultured in DMEM supple-
mented with 10% FCS, penicillin, and streptomycin. COS-7 
cells were used in immunofluorescence experiments because 
they are easy to transfect. Primary human keratinocytes 
(PHKs) were cultured in KGM-2 Medium (Promocell, 
Heidelberg, Germany). Phoenix cells were cultured as pre-
viously described [22] for the generation of recombinant 
retroviruses.
Plasmids and transfections
Retroviral constructs for the expression of HPV5 and HPV8 
E6, E7, E6E7 and HPV16 E6E7 were generated using the 
pLXSN vector. These constructs were transfected into Phoe-
nix cells, and retroviruses were subsequently isolated and 
used to transduce PHK cells as previously described [22]. 
HPV5 E7 mutants I2P, Δ26-29, E31G, R66E, and Δ79-83 
cloned into pcDNA3.1(−) were obtained from Dr. Ramon 
Garcia-Escudero (CIEMAT, Madrid, Spain) and then fur-
ther subcloned into a pGEX4T3 vector for the expression 
of N-terminal GST fusion proteins. Expression constructs 
pCMV-SPORT-3xFLAG-E6 or -E7 of HPV5 or HPV8 were 
generated for expression of fusion proteins coding for triple 
flag-tagged viral proteins [23] to be used in immunoprecipi-
tation experiments. HPV5 and HPV8 E6 and E7 genes were 
subcloned into pCMV to express fusion proteins with the 
AU1 epitope tag for immunofluorescence analyses.
Yeast two‑hybrid system
In order to identify cellular proteins binding to HPV5 E6 
or E7 oncogenes, the Matchmaker two-hybrid system was 
used together with a cDNA library from the HaCaT human 
keratinocyte cell line (Clontech, Saint-Germain-en-Laye, 
France). Either E6 or E7 was used as a bait. Identification 
of binding proteins was performed by MALDI-TOF as previ-
ously described [24].
GST pulldown experiments
Preparation of GST fusion proteins and GST pulldown 
experiments were performed as previously described [23]. 
In these experiments both wild-type (wt) HPV5 and HPV8 
E7 as well as the HPV5 E7 mutants I2P, Δ26-29, E31G, 
R66E, I67R, and Δ79-83 were used.
Immunoblotting, immunoprecipitation, 
and confocal microscopy
Primary antibodies used in immunoblotting, immunopre-
cipitation, and immunofluorescence are described in Sup-
plementary Table 1. Proteins were separated by SDS-PAGE, 
transferred to PVDF membranes and immunoblotted with 
the corresponding antibodies, and detection was carried out 
using ECL. Immunoprecipitation of flag-tagged E6 or E7 
proteins was performed as previously described [23]. For 
immunofluorescence experiments, cells were grown on 
coverslips and subsequently transfected with expression 
constructs, fixed with 3% paraformaldehyde, washed, and 
incubated with primary antibodies. Secondary antibodies 
were labeled with Alexa488 or Alexa594 (Invitrogen, Carls-
bad, CA). Images were generated using a Zeiss LSM 700 or 
a Leica TCS SP microscope.
Cell cycle and DNA content analysis
Transduced and control PHK cells were treated for 24 h with 
nocodazol, fixed, stained with propidium iodide, and analyzed 
for DNA content by FACS. The experiments were repeated 
twice, each time with two biological replicates. FACS analy-
ses were performed on a FACSCalibur flow cytometer (BD 
Biosciences, San Jose, CA) using fixed cells. The data were 
analyzed using CellQuest (BD Biosciences) as well as FlowJo 
(Tree Star, Ashland, OR) as described elsewhere [25]. Trans-
duced as well as control PHK cells were exposed to BrdU 
for 45 min, fixed and stained using fluorescein-labeled BrdU 
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antibodies (Supplementary Table 1). BrdU incorporation was 
measured using FACS analysis.
Centrosome number quantification
In order to quantify centrosome numbers, PHK were trans-
duced with retroviruses, fixed in PFA and then stained with 
antibodies targeting pericentrin. DNA was visualized by DAPI 
staining. The experiment was repeated twice, and the centro-
some numbers were calculated in a minimum of 200 cells per 
experiment with comparable results.
UV irradiation of the K14‑HPV8‑CER and FVB/n wt 
mice
Mouse lines used in this study included FVB/n wt (Charles 
River Laboratories, Sulzfeld, Germany) and the transgenic 
hemizygous FVB/N line K14-HPV8-CER [8]. UV irradia-
tion protocols were approved by the governmental animal 
care office North-Rhine-Westphalia (Leibnizstraße 10, 45659 
Recklinghausen, Protocol No. 8.87-50.10.35.08.163) and were 
in accordance with the German Animal Welfare Act as well 
as the German Regulation for the protection of animals used 
for experimental purposes. For UV treatment, age (5 weeks) 
and sex-matched mice were shaved and irradiated once with 
10 J/cm2 UVA and 1 J/cm2 UVB on a 4 cm2 sized dorsal cau-
dal area. All offspring were macroscopically examined for the 
presence of skin lesions on day 24 after UV treatment. On 
day 24 after UV irradiation the animals were sacrificed and 
samples of the irradiated skin were collected, fixed, and sub-
sequently embedded in paraffin.
Sections of EV skin lesions and organotypic cultures
Human EV biopsy material from archival paraffin blocks taken 
during routine surgical excision (for detailed information see 
[26]) was used in this study. Ethical approval for the use of 
human samples was obtained from the Ethics Committee of 
the Medical University of Warsaw.
The generation of organotypic skin cultures of keratinocytes 
expressing HPV5, HPV8, or HPV16 E7 was based on a de-
epidermalized human dermis serving as the dermal equivalent, 
which was then repopulated with PHKs. These 3D cultures 
were grown for 14 days at the air–liquid interphase, followed 
by fixing and embedding in paraffin [10].
Results
Identification and validation of NuMA 
among binding partners of betaHPV E6 and E7
In order to identify putative interaction partners of E6 and 
E7 of HPV5, yeast two-hybrid screens were performed. 
Among the putative E6 interaction partners we identified 
NuMA. Subsequent in vitro GST pulldown experiments con-
firmed the interaction between NuMA and E6 as well as E7 
of HPV5 and HPV8 (Fig. 1a). Furthermore, 293T cells were 
transfected separately with pCMV-SPORT-3xFLAG-E6 or 
-E7 expression constructs coding for flag-tagged HPV5 and 
HPV8 E6 or E7 proteins. Immunoprecipitation with extracts 
from transfected cells was then performed with anti-flag 
antibodies. Again, NuMA coprecipitated with E6 and E7 
proteins of both HPV5 and HPV8, and E6 binding was con-
sistently shown to be stronger than E7 binding (Fig. 1b).
NuMA binding is independent of the pRb binding 
site of E7
Binding of HPV16 E7 to NuMA is known to be dependent 
on the pRb binding domain of E7 [15]. In order to analyze 
whether betaHPV might share this property we performed 
binding experiments using N-terminal GST fusion con-
structs of wt HPV5 E7 as well as the E7 variant Δ26-29, 
known to be defective in respect to pRb binding [27] and 
additional constructs mutated at positions I2P (abrogating 
hydrophobicity), E31G, R66E, I67R (which all changed the 
charged at their respective positions) or Δ79-83 (deletion 
of the zinc finger domain [28]). The GST pulldown experi-
ments showed no significant reduction in NuMA binding 
by any of the tested E7 mutants (Fig. 1c). We therefore con-
cluded that regions outside the pRb binding and zinc finger 
domain are required for NuMA binding by HPV5 E7.
Expression of NuMA in betaHPV‑positive skin
In order to characterize NuMA expression in betaHPV-pos-
itive differentiating epithelia, we first studied the staining 
pattern of NuMA in the skin of K14-HPV8-CER transgenic 
mice. These mice develop skin tumors 3 weeks following 
UV exposure, whereas the FVB/n wt mice heal from UV-
induced hyperplasia [9, 29]. In FVB/n wt skin, which healed 
from UV-induced hyperplasia, NuMA is mainly expressed 
in the hair follicles, with weak staining of the interfolli-
cular epidermis (Fig. 2a). In skin tumors of K14-HPV8-
CER mice, elevated expression of NuMA throughout the 
epithelium was observed. In healthy human skin, nuclear 
NuMA appeared to be evenly distributed throughout the 
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basal cell layer with decreasing staining intensity toward 
the skin surface. In skin SCC sections from EV patients we 
detected different staining patterns. For instance, in section 
EV-a, NuMA is mainly nuclear but also cytoplasmic and 
restricted to the suprabasal cell layers. Unexpectedly, in the 
skin SCC section EV-b NuMA has a mainly cytoplasmic 
staining profile (Fig. 2b). Interestingly, in organotypic skin 
cultures of control keratinocytes, NuMA is exclusively cyto-
plasmic. The same holds true for the HPV8 E7 skin culture 
with stronger staining intensity in the suprabasal cell layers 
(Fig. 2c).
E6 and E7 and NuMA colocalize in interphase
We next studied the subcellular localization of E6 or E7 and 
NuMA by means of immunofluorescence and laser confo-
cal microscopy. Cells were transfected with expression con-
structs coding for AU1-tagged E6 or E7 fusion proteins of 
HPV5 and HPV8. The cells were then fixed and stained with 
a specific antibody targeting AU1. Nuclear NuMA expres-
sion in interphase COS-7 cells was shown, which proved 
not to be altered by expression of HPV5 or HPV8, E6 and 
E7 (Fig. 3a). Similar findings were obtained in transfected 
293T cells (data not shown). The E7 proteins colocalized 
with NuMA in interphase nuclei. Manders coefficient for 
colocalization was 0.45–0.54 for E6 and 0.78–0.91 for E7 
(Supplementary Fig. 1). Additional weak cytoplasmic stain-
ing was shown for the E6 protein. Next, we looked at a pos-
sible colocalization of AU1-tagged HPV5 E7 mutants with 
NuMA. All mutants colocalized with NuMA in the nucleus, 
comparable to wt E7. Manders coefficient for colocaliza-
tion was 0.8–0.85 for the different mutants (Supplemen-
tary Fig. 1). This result is in line with the GST pulldown 
experiments, further reinforcing the notion that interaction 
with NuMA is not dependent on the pRb binding domain 
of HPV5 E7.
E7 but not E6 colocalizes with NuMA at mitotic 
spindle poles
A central function of NuMA is the alignment and stabi-
lization of microtubules of the mitotic spindle. We there-
fore studied the localization of E6 and E7 of both HPV5 
and HPV8 as well as NuMA in cells undergoing mitosis. 
AU1-tagged E6 and E7 proteins were expressed in COS-7 
cells, and the cells were fixed and further analyzed using 
Fig. 1  HPV5 and HPV8 E6 and 
E7 bind to NuMA. a Lysates 
of 293T cells were subjected 
to GST pulldown using HPV5 
and HPV8 E6 or E7 GST 
fusion proteins. One-tenth of 
the extract was used as loading 
control. Antibodies against 
GST and NuMA were used in 
immunoblotting. b 293T cells 
were transfected with expres-
sion constructs coding for 
flag-tagged HPV5 and HPV8 
E6 and E7 proteins. Cell lysates 
were analyzed by immunopre-
cipitation and immunoblotting 
using antibodies against the 
flag epitope or NuMA *E7 
multimer. c NuMA binding by 
wild-type and mutant HPV5 E7 
proteins. 293T cell lysates were 
subjected to GST pulldown 
using wild-type or mutant GST 
E7 fusion proteins. Immunob-
lotting was performed with anti-
bodies against GST or NuMA
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immunofluorescence and laser confocal microscopy. Both 
HPV5 and HPV8 E7 were found to colocalize with NuMA 
at spindle poles in mitotic cells (Fig. 3b). Surprisingly, 
no colocalization of E6 with NuMA was observed during 
mitosis. Most intriguingly, in a small subset of cells, E7 of 
both HPV5 and HPV8 was seen at only one spindle pole 
in dividing cells, whereas NuMA still localized at both 
poles (Fig. 3b).
Fig. 2  NuMA expression in 
HPV8 positive skin. a Sec-
tions of UV-irradiated skin 
from FVB/n wt (top left) and 
K14-HPV8-CER mice (top 
right), harvested 24 days after 
UV treatment, were stained 
for NuMA. b Representative 
immunofluorescence staining of 
NuMA in healthy skin and two 
individual skin SCC from EV 
patients positive for HPV5, 8, 
20, 23, 36, 50. c Representative 
immunofluorescence staining 
of NuMA in organotypic skin 
cultures, which were repopu-
lated with PHK harboring the 
empty retroviral vector pLXSN 
(control) or HPV8 E7, respec-
tively, and grown for 14 days at 
the air–liquid interphase (blue 
DAPI, green NuMA, dashed 
line basement-membrane zone, 
d dermis, e epidermis)
A
B
FVB/n wt K14-HPV8-CER
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HPV5 or HPV8 E7 do not induce marked aneuploidy
Based on our observation that E7 and NuMA colocalize in 
mitotic cells we next asked whether this might interfere with 
NuMA function during mitosis. In particular, we were inter-
ested to see whether the possible interference may impact 
the stability or lead to misalignment of chromosomes at the 
mitotic spindle in metaphase. As such associations have 
previously been described for HPV16 [30–33], we trans-
duced PHK cells with HPV5, HPV8 or with HPV16 E6E7 
retroviral constructs for comparison. After undergoing 
selection, the cells were stained with propidium iodide and 
analyzed by FACS. No increase in DNA content above 4N 
was observed for any of the different viral proteins (Sup-
plementary Fig. 2a, c). We next treated the transduced PHK 
cells with nocodazole, a reagent inhibiting polymerization 
of microtubuli and causing cell cycle arrest through activa-
tion of the spindle checkpoint. The increase in the > 4N cell 
population still remained insignificant, except for HPV16 
E6E7, which showed a 5.5-fold increase in the > 4N popula-
tion as compared to empty vector control (Supplementary 
Fig. 2b, c). Collectively, we conclude that betaHPV E6E7 
proteins do not markedly induce aneuploidy in epithelial 
cells in vitro.
Cell cycle is not altered due to betaHPV E7
Interaction of HPV16 E7 with NuMA leads to destabiliza-
tion of the mitotic complex of NuMA with dynein and con-
sequently to chromosomal misalignment in prometaphase. 
This may in turn result in a prolonged mitosis, as has already 
been shown for HPV16 in NIH3T3 cells [15]. We therefore 
A B
IF: anti-AU1 anti-NuMA anti-AU1 anti-NuMA
colocalizing pixelsmerge
Mock
HPV5 E6
colocalizing pixelsmerge
HPV5 E7
HPV8 E6
HPV8 E7
merge colocalizing pixels
anti-AU1 anti-NuMA
Fig. 3  E6 and E7 and NuMA colocalize in interphase. a COS-7 
cells were transfected with expression plasmids for HPV5 or HPV8 
E6 or E7 provided with AU1 epitope. Fixed cells were stained with 
antibodies to AU1 (green) or NuMA (red). The images show z-axis 
projections of 15–18 layers. Colocalized pixels were calculated using 
the Colocalization Highlighter Plugins of ImageJ. Only those pixels 
which exceeded the cutoff intensity of 100 (8 bit) and whose intensi-
ties on both channels showed at least 95% correlation were taken into 
account. b E7 and NuMA colocalize at mitotic spindle poles. Immu-
nofluorescence showing NuMA (red) and AU1-E7 (green) in COS-7 
cells expressing either HPV5 or HPV8 E7. The two separate four-
field images show stainings in two individual cells (red arrow: indi-
cates spindle pole without E7)
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wanted to explore whether the interaction of betaHPV onco-
genes with NuMA may affect the cell cycle in epithelial 
cells in a similar fashion. To this end, nonsynchronized PHK 
cells were transduced with pLXSN constructs coding for 
the different E6E7 proteins. The cells were then incubated 
with bromouridine, fixed, stained, and examined by FACS 
analysis. None of the E6E7 proteins disrupted the cell cycle 
profile to a significant degree (Supplementary Fig. 3a, b). 
Prolonged prometaphase should have led to an increased 
cell population in the G2/M phase which was, however, not 
observed for any of the E6E7 constructs (Supplementary 
Fig. 3a, b). The experiment was repeated in 293T and NIKS 
cells with comparable results (data not shown). The > 4N 
cell population was only found to be increased in HPV16 
E6E7 expressing cells (Supplementary Fig. 3a, b), which 
was in line with the results from the nocodazole experiment 
described above (Supplementary Fig. 2b, c).
BetaHPV E7 does not induce aberrant centrosome 
distribution
PHK were transduced with retroviral constructs for 
E6E7 proteins, fixed, and stained for pericentrin, and the 
number of centrosomes was counted. HPV5 or HPV8 E6E7 
caused minimal changes in centrosome numbers, whereas 
the changes due to HPV16 E6E7 expression were consider-
able. We conclude that while HPV16 E6E7 have a strong 
effect on centrosome duplication, neither HPV5 nor HPV8 
E6E7 appears to have this ability (Fig. 4).
Discussion
The role of alphaHPV in cancers at mucosal sites such as the 
anogenital region and the head and neck region is well estab-
lished [34]. How betaHPV is involved in skin carcinogenesis 
is not well understood as betaHPV DNA is less frequently 
found and is only present in negligible copies per cell in skin 
cancers. In this respect, a hit-and-run mechanism has been 
proposed for betaHPV in skin carcinogenesis, a hypothesis 
which is further supported by experimental models [35–37], 
suggesting that betaHPV acts as a tumorigenic trigger but 
is dispensable at later tumor stages. Both alphaHPV and 
betaHPV exert certain tumorigenic functions. For instance, 
they both bind pRb [11], which leads to its degradation 
[12]. Furthermore, it has been shown that HPV16 E7 binds 
to NuMA, and the binding motif is located within the pRb 
binding domain [15]. We now show that betaHPV E7 pro-
teins are also capable of binding NuMA. However, the inter-
acting region does not seem to be located within the pRb 
binding domain, contrary to HPV16 E7. In interphase cells, 
NuMA is a key component of the nuclear matrix, and it is 
also involved in the reassembly of the nucleus following 
mitosis (reviewed in [38]). During mitosis, NuMA orches-
trates correct organization of microtubules at centrosomes 
and proper chromosome alignment in preparation of cell 
division. Contrary to HPV16 E7 [39, 40], only a small pro-
portion of betaHPV E6E7 expressing cells display extra cen-
trosomes, suggesting that there is only a minor interference 
with centrosome separation upon betaHPV E6E7 binding to 
pLXSN HPV5 
E6E7
> 2
HPV8 
E6E7
1 or 2
HPV16 
E6E7
A
B
C
Fig. 4  PHK were transduced with pLXSN vector, or constructs 
expressing E6 and E7 of either HPV5, HPV8 or HPV16, and the cells 
were stained for pericentrin (red). a Left image: control; right image: 
HPV5-E6E7. b Left image: HPV8-E6E7; right image: HPV16-
E6E7. c Proportions in percentages of HPV5, HPV8 or HPV16 E6E7 
expressing cells with more than two centrosomes. The experiment 
was repeated twice, and each time 100–200 cells were taken into 
account
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NuMA. In summary, we report that betaHPV E6E7 binding 
to NuMA has only a minor effect in respect to cellular DNA 
content, cell cycle or the number of centrosomes, which has 
also been shown in the past for HPV16 E7 [41].
Although we did not observe relocalization of NuMA due 
to betaHPV oncogene binding in 2D tissue cultures, ECM 
signaling-dependent redistribution of NuMA has previously 
been shown in carcinogenesis and in differentiation [42]. We 
therefore analyzed NuMA distribution patterns in the skin of 
K14-HPV8-CER transgenic mice, in HPV8 positive EV skin 
SCC, as well as in 3D organotypic skin cultures of HPV8 E7 
expressing keratinocytes. In FVB/n wt murine skin as well 
as skin tumors from transgenic mice, NuMA is located in the 
nucleus. Unexpectedly, the analyses of SCC skin from dif-
ferent EV patients showed distinct NuMA staining patterns. 
We observed nuclear localization but, intriguingly, we also 
found tumors with mainly cytoplasmic NuMA. Curiously, 
in human 3D skin cultures, which can also be regarded as 
a wound healing model, NuMA was exclusively cytoplas-
mic. HPV8 E7 did not affect the distribution, but rather 
the total expression levels in suprabasal cells. Whether the 
two distinct NuMA staining patterns are linked to distinct 
cells of origin of skin SCC [43], or whether wound healing 
processes may affect the subcellular distribution of NuMA 
are questions which would most certainly warrant further 
investigation.
In addition to symmetric cell division, NuMA has an 
important function in establishing cell polarity required 
for asymmetric cell division taking place in, e.g., basal epi-
thelial cells, where one daughter cell retains its basal iden-
tity, whereas the other cell is committed to differentiation. 
NuMA is responsible, together with dynein, for positioning 
the minus ends of microtubules at the poles of the mitotic 
spindle [44]. A dysfunction of NuMA–dynein complexes 
may therefore lead to failure in spindle formation and incor-
rect orientation of metaphase chromosomes. We now show 
that HPV8 E6E7 proteins bind and colocalize with NuMA in 
interphase nuclei. However, only E7 associates with NuMA 
at the poles of the mitotic spindle. It is intriguing that in a 
small fraction of cells E7 colocalizes with NuMA at only 
one of the spindle poles. It is tempting to speculate that the 
asymmetric E7 distribution might alter the proportions of 
basal or stem cells undergoing asymmetric versus symmetric 
division in infected skin. Asymmetric basal cell division is a 
prerequisite for epithelial differentiation, and it enables and 
supports the completion of the HPV replication cycle. A 
potential shift of the balance toward symmetric cell division 
in the basal cell layer would, however, increase the number 
of stem-like cells, and possibly trigger neoplastic develop-
ment. We recently provided further support for this idea by 
showing that particularly the expression of HPV8 E7 in vitro 
increases the number of stem-like cells in colony-formation 
and tumor sphere assays, thus facilitating the initiation of 
oncogenic events, which is also relevant for the hit-and-
run hypothesis of betaHPV-mediated skin carcinogenesis 
[45]. Understanding the molecular basis of NuMA distribu-
tion may be relevant for asymmetric/symmetric division in 
betaHPV-infected epithelia and should be a topic for further 
research.
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